MCL1 and lip and oral cavity carcinoma: Our study for the first time assessed Mcl-1 splice variants in oral cancer and demonstrated, anti-apoptotic Mcl-1L isoform to be a chemoresistance and prognostic factor and a potential therapeutic target in oral cancers.